Patents by Inventor Arthur Adam Nagel

Arthur Adam Nagel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7119207
    Abstract: The present invention relates to certain benzoamide piperidine containing compounds and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: October 10, 2006
    Assignee: Pfizer INC
    Inventors: Brian Thomas O'Neill, Arthur Adam Nagel, John Michael Humphrey, Susan Beth Sobolov-Jaynes, Thomas Allen Chappie, Lawrence Albert Vincent, Eric Platt Arnold, Jianhua Huang
  • Publication number: 20030087925
    Abstract: The present invention relates to certain benzoamide piperidine containing compounds and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders.
    Type: Application
    Filed: March 16, 2001
    Publication date: May 8, 2003
    Inventors: Brian Thomas O'Neill, Arthur Adam Nagel, John Michael Humphrey, Susan Beth Sobolov-Jaynes, Thomas Allen Chappie, Lawrence Albert Vincent, Eric Platt Arnold, Jianhua Huang
  • Patent number: 6124321
    Abstract: Compounds of the formula ##STR1## wherein ring A, ring B, ring D, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6,R.sup.11, R.sup.12, R.sup.13, E, G, X and P are as defined below. The compounds of formula I are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: September 26, 2000
    Assignee: Pfizer Inc
    Inventors: Yuhpyng Liang Chen, Arthur Adam Nagel
  • Patent number: 5965574
    Abstract: Compounds of the formula ##STR1## wherein ring A, ring B, ring D, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.11, R.sup.12, R.sup.13, E, G, X and P are as defined below. The compounds of formula I are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.
    Type: Grant
    Filed: August 13, 1996
    Date of Patent: October 12, 1999
    Inventors: Yuhpyng Liang Chen, Arthur Adam Nagel